KR930004286A - 마일라르 반응 억제제 - Google Patents

마일라르 반응 억제제 Download PDF

Info

Publication number
KR930004286A
KR930004286A KR1019920015455A KR920015455A KR930004286A KR 930004286 A KR930004286 A KR 930004286A KR 1019920015455 A KR1019920015455 A KR 1019920015455A KR 920015455 A KR920015455 A KR 920015455A KR 930004286 A KR930004286 A KR 930004286A
Authority
KR
South Korea
Prior art keywords
group
phenyl
compound
lower alkyl
phenyl ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019920015455A
Other languages
English (en)
Korean (ko)
Inventor
게이스케 미야지마
본페이 야스이
마사아키 모토야마
신타로 이시카와
고이치 야스무라
Original Assignee
오츠카 아키히코
오츠카 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오츠카 아키히코, 오츠카 세이야쿠 가부시키가이샤 filed Critical 오츠카 아키히코
Publication of KR930004286A publication Critical patent/KR930004286A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019920015455A 1991-08-27 1992-08-27 마일라르 반응 억제제 Ceased KR930004286A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP91-215621 1991-08-27
JP21562191 1991-08-27

Publications (1)

Publication Number Publication Date
KR930004286A true KR930004286A (ko) 1993-03-22

Family

ID=16675440

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920015455A Ceased KR930004286A (ko) 1991-08-27 1992-08-27 마일라르 반응 억제제

Country Status (7)

Country Link
US (1) US5422360A (enExample)
EP (1) EP0531812A1 (enExample)
KR (1) KR930004286A (enExample)
CN (1) CN1034864C (enExample)
AU (1) AU649158B2 (enExample)
CA (1) CA2077032A1 (enExample)
TW (1) TW221689B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0679088T3 (da) * 1992-09-29 2002-10-28 Inhale Therapeutic Syst Pulmonal levering af aktive fragmenter af parathyreoideaea hormon
ATE212018T1 (de) * 1993-02-26 2002-02-15 Otsuka Pharma Co Ltd Thiazole oder imidazole derivate als maillard reaktion inhibitoren
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
DE69535897D1 (de) 1994-03-07 2009-01-22 Nektar Therapeutics Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
GB2288732B (en) * 1994-04-13 1998-04-29 Quadrant Holdings Cambridge Pharmaceutical compositions
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
AU3117497A (en) 1996-05-21 1997-12-09 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
WO1998043649A2 (en) * 1997-03-28 1998-10-08 Otsuka Pharmaceutical Co., Ltd. Age production inhibitory composition comprising a maillard reaction inhibitor and vitamin b¿6?
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
BRPI0416752B8 (pt) 2003-11-21 2021-05-25 Actelion Pharmaceuticals Ltd composição farmacêutica, uso de um ou mais compostos, e, compostos
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
DK2094676T3 (da) * 2006-11-23 2013-06-10 Actelion Pharmaceuticals Ltd Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
HUE050733T2 (hu) 2012-08-17 2021-01-28 Actelion Pharmaceuticals Ltd Eljárás (2Z,5Z)-5-(3-klór-4-((R)-2,3-dihidroxipropoxi)benzilidén)-2-(pro-pilimino)-3-(O-tolil)tiazolidin-4-on elõállítására és ezen eljárásban alkalmazott köztitermék
CN106620745B (zh) * 2015-11-02 2019-10-11 中国石油化工股份有限公司 一种降低培养基灭菌过程中的美拉德反应的方法
CN107522311A (zh) * 2017-10-19 2017-12-29 王云龙 一种净水机
CN114315753B (zh) * 2020-09-30 2023-11-21 烟台药物研究所 一种化合物、其合成方法与应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB132914A (enExample) *
DE381628C (de) * 1923-09-22 Gegauf & Co Nadelkluppe fuer Handstickmaschinen
DE185346C (enExample) *
GB181779A (en) * 1921-02-19 1922-06-19 Henry Ramsden Improvements in covers or gaiters for laminated vehicle springs
DE929549C (de) * 1951-11-29 1955-08-01 Hoechst Ag Verfahren zur Herstellung substituierter Pseudothiohydantoine und ihrer Hydrohalogenide
DE932674C (de) * 1952-12-06 1955-09-05 Hoechst Ag Verfahren zur Herstellung von N-Alkoxyphenyl-pseudothiohydantoinen
US2739971A (en) * 1954-03-29 1956-03-27 Eastman Kodak Co 5-benzal-3-n-cetyl-2-phenylimino-4-thiazolidone
DE1038050B (de) * 1955-11-17 1958-09-04 Farmaceutici Italia S A Soc Verfahren zur Herstellung von 5-(3', 4'-Dioxybenzyliden)-Derivaten heterocyclischer Verbindungen
FR1604530A (enExample) * 1967-06-06 1971-11-29
US3641019A (en) * 1968-08-30 1972-02-08 Dow Chemical Co Thiazolo-as-triazines
AR204619A1 (es) * 1973-02-13 1976-02-20 Ciba Geigy Ag Procedimiento para la elaboracion de un nuevo derivado de 2,2-azina-2,4-tiazolidindiona
US4402964A (en) * 1981-11-16 1983-09-06 Mcneilab, Inc. N-Aryl-N'-(3-methyl or ethyl-4-oxothiazolidinylidene)ureas useful for the treatment of epilepsy
DE3146299A1 (de) * 1981-11-17 1983-06-01 Schering Ag, 1000 Berlin Und 4619 Bergkamen Thiazolo- und (1,3)thiazino(2,3-c)(1,2,4)triazinone mit selektiver herbizider wirkung sowie verfahren zur herstellung dieser verbindungen
DE3302413A1 (de) * 1983-01-21 1984-07-26 Schering AG, 1000 Berlin und 4709 Bergkamen Triazinone, verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit selektiver herbizider wirkung
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
US4908446A (en) * 1985-11-14 1990-03-13 The Rockefeller University Inhibitors of nonenzymatic cross-linking
DE3446812A1 (de) * 1984-12-21 1986-06-26 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4657922A (en) * 1985-05-24 1987-04-14 Mcneilab, Inc. Anxiolytic 4,5-dihydro-4-oxo-1H-imidazol-2-yl urea derivatives
JPS6456614A (en) * 1987-08-27 1989-03-03 Ono Pharmaceutical Co Maillard reaction inhibitor
JPS6483059A (en) * 1987-09-25 1989-03-28 Ono Pharmaceutical Co Guanidine derivative, its production and maillard reaction inhibitor containing said derivative as active component
DE3841879A1 (de) * 1988-12-13 1990-06-21 Boehringer Mannheim Gmbh Neue imidazolidin-derivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US4957936A (en) * 1989-02-01 1990-09-18 Nippon Zoki Pharmaceutical Co., Ltd. Glycocyamidine derivatives

Also Published As

Publication number Publication date
EP0531812A1 (en) 1993-03-17
CN1069728A (zh) 1993-03-10
CN1034864C (zh) 1997-05-14
AU2131192A (en) 1993-03-04
AU649158B2 (en) 1994-05-12
US5422360A (en) 1995-06-06
CA2077032A1 (en) 1993-02-28
TW221689B (enExample) 1994-03-11

Similar Documents

Publication Publication Date Title
CA2152819A1 (en) New antiparasitic agents related to the milbemycins and avermectins
CA2264155A1 (en) N6 heterocyclic substituted adenosine derivatives
KR920700209A (ko) 치환된 벤조[5,6]사이클로헵타피리딘의 헤테로사이클릭 n-옥사이드 유도체, 조성물 및 용도
AU6801090A (en) Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
KR870008889A (ko) 베타-락탐화합물, 및 그의 제조 방법
CA2119853A1 (fr) Nouvelles pyridothiadiazines, leurs procedes de preparation, et les compositions pharmaceutiques qui les contiennent
IE892232L (en) Heterocyclic compounds
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
KR920000766A (ko) 4급 암모늄 치환 프로페닐기를 제3위치에 함유하는 세팔로스포린류, 이들의 제조방법, 이들의 의약으로서의 용도, 이들을 함유하는 조성물 및 중간체
KR950011462A (ko) 호르몬 활성이 저하된 에스트라디올 유도체-알킬화제 결합체, 그의 제조방법, 그의 제조에 유용한 화합물, 및 상기 결합체 또는 에스트라디올 유도체를 함유하는 성장억제조성물
BR9504576A (pt) Esteróide processo para a preparaçao do mesmo composiçao farmacêutica uso do esteróide e processo de contracepçao
KR950000026A (ko) 살진균제 조성물
AU6476394A (en) 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position 11beta, preparation process and intermediates, use as medicaments and pharmaceutical compositions containing them
KR850007427A (ko) 항균 화합물의 제조방법
EP0643966A4 (en) ACTIVE SUBSTANCE FOR IMPROVING SENSITIVITY TO ANTINEOPLASTIC ACTIVE SUBSTANCES.
KR900003177A (ko) 테트라시클릭계 우울증 치료제
KR910006294A (ko) 피롤로피리미딘, 그의 제법 및 용도
KR910009702A (ko) 크산틴 화합물, 그 제조방법 및 약학적 조성물
KR920701144A (ko) 아미노산 유도체
KR890013019A (ko) 과뇨산혈증을 치료하는데 있어서의 옥소퀴나졸린 유도체의 용도
KR860000265A (ko) 치환된 아자비사이클로헵탄의 제조방법
KR930701454A (ko) 페넴 화합물
KR830001900A (ko) 페닐모르판과 그의 중간물질및 제조방법
AU565564B2 (en) Tetrahydro-1,3-thiazin-2,4-dione, utilization thereof and skin treating agents containing said compound
KR920002613A (ko) 이환성 함유 황화합물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19920827

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19970425

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19920827

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19981230

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19990326

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19981230

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I